Does Dr. MATTHEW BORNS have financial conflicts of interest?

Dr. MATTHEW BORNS (D.P.M.) has received a total of $321 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $321 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. MATTHEW BORNS?

According to CMS Open Payments data, Dr. MATTHEW BORNS received funding from TREACE MEDICAL CONCEPTS ($132), SEBELA PHARMACEUTICALS ($88), and ORTHO DERMATOLOGICS, A DIVISION OF BAUSCH HEALTH US ($33).

Does Dr. MATTHEW BORNS receive research grants or speaking fees?

Dr. MATTHEW BORNS has received $321 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. MATTHEW BORNS

D.P.M.Real-Time Hydrated

Specialty: Podiatrist, Foot & Ankle Surgery

Practice Location: CHARLOTTE, NC 28210

NPI Number: 1891046454

LIFETIME INDUSTRY VALUE

$321

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. BORNS is a verified Podiatrist, Foot & Ankle Surgery practitioner based in CHARLOTTE, NC.

Between 2021 and 2025, Dr. BORNS had an overall industry promotional and research financial footprint of $321 as recorded in the federal CMS Open Payments database.

$321 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. BORNS's primary funding source is TREACE MEDICAL CONCEPTS, which accounts for $132 (representing 41.2% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

TREACE MEDICAL CONCEPTS

Rank 1

$132

41.2%

SEBELA PHARMACEUTICALS

Rank 2

$88

27.3%

ORTHO DERMATOLOGICS, A DIVISION OF BAUSCH HEALTH US

Rank 3

$33

10.2%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.